Difference between revisions of "Template:SPCaripiprazoleLA"
From Psychiatrienet
| (2 intermediate revisions by the same user not shown) | |||
| Line 1: | Line 1: | ||
* More information you'll find in the summary of product characteristics (SPC) of aripiprazole depot injection. <ref>https://www.ema.europa.eu/en/medicines/human/EPAR/abilify-maintena SPC of the European Medicines Agency on aripiprazole depot</ref> | * More information you'll find in the summary of product characteristics (SPC) of aripiprazole depot injection. <ref>https://www.ema.europa.eu/en/medicines/human/EPAR/abilify-maintena SPC of the European Medicines Agency on aripiprazole depot</ref> | ||
| − | * Aripiprazol Abilify Maintena is a prolonged release suspension for injection and is available in 400mg and 960mg | + | * Aripiprazol Abilify Maintena is a prolonged release suspension for injection and is available in 300mg and 400mg (once a month) and 720mg and 960mg (once every two months). |
Latest revision as of 12:33, 20 February 2025
- More information you'll find in the summary of product characteristics (SPC) of aripiprazole depot injection. [1]
- Aripiprazol Abilify Maintena is a prolonged release suspension for injection and is available in 300mg and 400mg (once a month) and 720mg and 960mg (once every two months).
